30
Participants
Start Date
November 12, 2019
Primary Completion Date
February 27, 2024
Study Completion Date
February 27, 2024
Imlifidase
All subjects will receive imlifidase (Day 1) prior to standard care IVIg
Hôpital de la Timone - Centre de référence des maladies neuromusculaires et de la SLA, Marseille
CHU Bordeaux - Hôpital Pellegrin Tripode, Bordeaux
CHU de Montpellier, Hôpital Gui de Chauliac, Montpellier
Centre Hospitalier Universitaire de Nantes, Nantes
CHU de Limoges - Hôpital Dupuytren, Limoges
CHU Le Kremlin-Bicêtre. Service Neurologie, Le Kremlin-Bicêtre
Service de neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg
Amsterdam UMC, Amsterdam
Queen Elizabeth University Hospital Glasgow, Glasgow
Oxford University Hospital, Oxford
Erasmus Medical Centre, Rotterdam
Lead Sponsor
Hansa Biopharma AB
INDUSTRY